
Implementation of a Bispecific T-Cell Engager Therapy Program at a Community Cancer Center
Development of this comprehensive bispecific antibody program included policy development; toxicity management; creation of patient and staff education documents; creation of clinician tools like a toxicity scoring and charting tool and an electronic order set that segregates treatment options; and a monitoring system to safely transition patients from inpatient to outpatient care.
Guest:
Courtney VanHouzen, PharmD
PGY-2 Oncology Resident
Munson Healthcare, Cowell Family Cancer Center
Traverse City, Michigan
"While this [implementation of bispecific T-cell engager therapy] is not an easy…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.